Search

Carl Zeiss Meditec AG

Avatud

SektorTervishoid

57.15 -5.93

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

56.4

Max

60.65

Põhinäitajad

By Trading Economics

Sissetulek

-45M

16M

Müük

-89M

491M

P/E

Sektori keskmine

30.149

63.778

Aktsiakasum

0.36

Dividenditootlus

0.91

Kasumimarginaal

3.201

Töötajad

2,066

EBITDA

-41M

37M

Soovitused

By TipRanks

Soovitused

Neutraalne

12 kuu keskmine prognoos

+3.68% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

0.91%

2.39%

Turustatistika

By TradingEconomics

Turukapital

197M

5.3B

Eelmine avamishind

63.08

Eelmine sulgemishind

57.15

Uudiste sentiment

By Acuity

47%

53%

166 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Carl Zeiss Meditec AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

28. okt 2024, 11:15 UTC

Market Talk
Tulu

Med-Tech Stocks Drop Amid Subdued Demand in China -- Market Talk

Carl Zeiss Meditec AG Prognoos

Hinnasiht

By TipRanks

3.68% tõus

12 kuu keskmine prognoos

Keskmine 62.83 EUR  3.68%

Kõrge 86.5 EUR

Madal 50 EUR

Põhineb 10 Wall Streeti analüütiku instrumendi Carl Zeiss Meditec AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

10 ratings

3

Osta

6

Hoia

1

Müü

Tehniline skoor

By Trading Central

N/A / 65.65Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Sentiment

By Acuity

166 / 386 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders. This segment also provides devices for general ophthalmological examination and care, including slit lamps, refractometers, tonometers, optical coherence tomography devices, and fundus cameras; and devices for functional diagnostics (perimeters), as well as digital products for storage, evaluation, and sharing of clinical data. In addition, this segment offers surgical ophthalmology products comprising surgical microscopes, biometers, phacoemulsification, and vitrectomy devices; intraocular lenses for cataract patients; and systems and consumables for laser eye surgery. The Microsurgery segment provides products and solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, neuro, dental, and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.